Target hemoglobin level for EPO therapy in CKD

被引：16

作者：

Parfrey, PS ^{[1
]}

机构：

[1] Mem Univ Newfoundland, St John, NF, Canada

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2006年 / 47卷 / 01期

关键词：

D O I：

10.1053/j.ajkd.2005.11.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：171 / 173

页数：3

共 17 条

[1] Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC Study
Abramson, JL
Jurkovitz, CT
Vaccarino, V
Weintraub, WS
McClellan, W
[J]. KIDNEY INTERNATIONAL, 2003, 64 (02) : 610 - 615
[2] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
Besarab, A
Bolton, WK
Browne, JK
Egrie, JC
Nissenson, AR
Okamoto, DM
Schwab, SJ
Goodkin, DA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 584 - 590
[3] Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465
[4] The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Foley, RN
Parfrey, PS
Harnett, JD
Kent, GM
Murray, DC
Barre, PE
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) : 53 - 61
[5] Foley RN, 2000, J AM SOC NEPHROL, V11, P912, DOI 10.1681/ASN.V115912
[6] Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
Foley, RN
Parfrey, PS
Morgan, J
Barré, PE
Campbell, P
Cartier, P
Coyle, D
Fine, A
Handa, P
Kingma, I
Lau, CY
Levin, A
Mendelssohn, D
Muirhead, N
Murphy, B
Plante, RK
Posen, G
Wells, GA
[J]. KIDNEY INTERNATIONAL, 2000, 58 (03) : 1325 - 1335
[7] Association of achieved dialysis dose with mortality in the Hemodialysis Study: An example of "dose-targeting bias"
Greene, T
Daugirdas, J
Depner, T
Allon, M
Beck, G
Chumlea, C
Delmez, J
Gotch, F
Kusek, JW
Levin, N
Owen, W
Schulman, G
Star, R
Toto, R
Eknoyan, G
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11): : 3371 - 3380
[8] Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
Henke, M
Laszig, R
Rübe, C
Schäfer, U
Haase, KD
Schilcher, B
Mose, S
Beer, KGT
Burger, U
Dougherty, C
Frommhold, H
[J]. LANCET, 2003, 362 (9392) : 1255 - 1260
[9] Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization
Keith, DS
Nichols, GA
Gullion, CM
Brown, JB
Smith, DH
[J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (06) : 659 - 663
[10] LEYLANDJONES B, 2003, LANCET ONCOL, V5, P206

← 1 2 →